Amy Zarzeczny
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Amy Zarzeczny has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Timothy Caulfield
Faculty of Law and School of Public Health & Health Law Institute, University of Alberta, Edmonton, AB T6G 2H5, Canada
3 shared publications- Zubin Master
Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
3 shared publications - Christen Rachul
University of Manitoba
2 shared publications Jeremy Snyder
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
2 shared publicationsKathleen McNutt
Johnson Shoyama Graduate School of Public Policy, University of Regina, Regina, Saskatchewan S4S 7H9, Canada
2 shared publications- Megan Munsie
Murdoch Children's Research Institute, Melbourne, Australia; Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Australia
2 shared publications
Latest Publications
- 29 April 2026
- Published by Taylor & Francis in Regenerative Medicine
- p. 1-12
Factors that influence trust in non-standard stem cell therapies among patients with musculoskeletal conditions: a qualitative, constructivist grounded theory study
Stem cell interventions (SCIs) are an exciting area of regenerative medicine (RM) that may offer improved outcomes for many patients, including those suffering from musculoskeletal conditions. They can also raise regulatory tensions and policy challenges, including how to manage direct-to-consumer markets where nonstandard SCIs - those falling outside the standard of care and lacking sufficient evidence of safety or efficacy - are sold. Ongoing regulatory reform efforts in several countries, including Canada, to address these and other related issues would benefit from insights regarding what is important to patients for trust in SCIs and their providers. Through interviews involving eight participants with musculoskeletal conditions, this qualitative, constructivist grounded theory study presents a preliminary model of factors that influence some patients' trust in nonstandard SCIs. Participants' anticipated approaches to nonstandard SCIs were rooted in their lived experiences of pain and frustration, shaped through interactions with healthcare providers, and framed by assumptions about regulatory protection. Healthcare providers play a pivotal role in helping navigate and interpret information. These results highlight the importance of evidence-based approaches to governance that integrate patient voices, practitioner education, and regulatory accountability to protect patients and help advance responsible RM innovation.
- 29 April 2026
- Published by Taylor & Francis in Regenerative Medicine
- p. 1-12
Factors that influence trust in non-standard stem cell therapies among patients with musculoskeletal conditions: a qualitative, constructivist grounded theory study
Stem cell interventions (SCIs) are an exciting area of regenerative medicine (RM) that may offer improved outcomes for many patients, including those suffering from musculoskeletal conditions. They can also raise regulatory tensions and policy challenges, including how to manage direct-to-consumer markets where nonstandard SCIs - those falling outside the standard of care and lacking sufficient evidence of safety or efficacy - are sold. Ongoing regulatory reform efforts in several countries, including Canada, to address these and other related issues would benefit from insights regarding what is important to patients for trust in SCIs and their providers. Through interviews involving eight participants with musculoskeletal conditions, this qualitative, constructivist grounded theory study presents a preliminary model of factors that influence some patients' trust in nonstandard SCIs. Participants' anticipated approaches to nonstandard SCIs were rooted in their lived experiences of pain and frustration, shaped through interactions with healthcare providers, and framed by assumptions about regulatory protection. Healthcare providers play a pivotal role in helping navigate and interpret information. These results highlight the importance of evidence-based approaches to governance that integrate patient voices, practitioner education, and regulatory accountability to protect patients and help advance responsible RM innovation.
- Open Access
- 18 June 2025
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 38 (5) , 496-505
Virtual care delivery in Saskatchewan: Multi-stakeholder perspectives on implementation, appropriateness, and evaluation
The purpose of this study was to provide an update on patients’, clinicians’, and health administrators’ experiences and perspectives on opportunities, barriers, and priorities for virtual care to inform health policy and planning as virtual care programs continue to mature and develop. Three surveys were developed and distributed in Saskatchewan, Canada. Quantitative data were analyzed using descriptive statistics and chi-squared tests, and free-text responses were analyzed using thematic analysis. Chronic disease management and mental health disorders were identified as highly suitable for virtual care. Health administrators underscored cost savings and improved patient access as key advantages, though they lacked consistent frameworks to assess virtual care effectiveness. Key barriers included digital literacy, technology constraints, and compensation models not aligned with virtual service provision. Participants called for greater infrastructure investment, technical support, and integrated electronic platforms. These insights may inform policy and practice to strengthen virtual health delivery and support health equity.
- 18 June 2025
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 38 (5) , 496-505
Open AccessVirtual care delivery in Saskatchewan: Multi-stakeholder perspectives on implementation, appropriateness, and evaluation
The purpose of this study was to provide an update on patients’, clinicians’, and health administrators’ experiences and perspectives on opportunities, barriers, and priorities for virtual care to inform health policy and planning as virtual care programs continue to mature and develop. Three surveys were developed and distributed in Saskatchewan, Canada. Quantitative data were analyzed using descriptive statistics and chi-squared tests, and free-text responses were analyzed using thematic analysis. Chronic disease management and mental health disorders were identified as highly suitable for virtual care. Health administrators underscored cost savings and improved patient access as key advantages, though they lacked consistent frameworks to assess virtual care effectiveness. Key barriers included digital literacy, technology constraints, and compensation models not aligned with virtual service provision. Participants called for greater infrastructure investment, technical support, and integrated electronic platforms. These insights may inform policy and practice to strengthen virtual health delivery and support health equity.
- Open Access
- 31 March 2022
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 35 (3) , 185-189
The future of artificial intelligence in medicine: Medical-legal considerations for health leaders
Artificial Intelligence (AI) is becoming increasingly common in healthcare and has potential to improve the efficiency and quality of healthcare services. As the utility of AI expands, medical-legal questions arise regarding the possible legal implications of incorporating AI into clinical practice. Particularly, the unique black box nature of AI brings distinct challenges. There is limited guidance addressing liability when AI is used in clinical practice, and traditional legal principles present limitations when applied to novel uses of AI. Comprehensive solutions to address the challenges of AI have not been well established in North America. As AI continues to evolve in healthcare, appropriate guidance from professional regulatory bodies may help the medical field realize AI’s utility and encourage its safe use. As the options for AI in medicine evolve, physicians and health leaders would be prudent to consider the evolving medical-legal context regarding use of AI in clinical practices and facilities.
- 31 March 2022
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 35 (3) , 185-189
Open AccessThe future of artificial intelligence in medicine: Medical-legal considerations for health leaders
Artificial Intelligence (AI) is becoming increasingly common in healthcare and has potential to improve the efficiency and quality of healthcare services. As the utility of AI expands, medical-legal questions arise regarding the possible legal implications of incorporating AI into clinical practice. Particularly, the unique black box nature of AI brings distinct challenges. There is limited guidance addressing liability when AI is used in clinical practice, and traditional legal principles present limitations when applied to novel uses of AI. Comprehensive solutions to address the challenges of AI have not been well established in North America. As AI continues to evolve in healthcare, appropriate guidance from professional regulatory bodies may help the medical field realize AI’s utility and encourage its safe use. As the options for AI in medicine evolve, physicians and health leaders would be prudent to consider the evolving medical-legal context regarding use of AI in clinical practices and facilities.
- 21 October 2021
- Published by Health Reform Observer - Observatoire des Reformes de Sante in Health Reform Observer – Observatoire des Réformes de Santé
- Vol. 9 (2)
Introducing an Organ Donor Registry is Saskatchewan
On 3 September 2020, Saskatchewan launched an organ donor registry that allows participants 16 years and older to register their intent to be an organ donor either online or using a paper form. Saskatchewan has historically performed poorly at a national level with low rates of organ donations. Saskatchewan's new registry is intended to increase the numbers of organ donors in the province, while also helping to modernize its organ donation system and ease donation conversations with families. Saskatchewan's introduction of this registry brought the province in line with other provinces and territories across Canada that use similar systems, and provided a response to the surge in public interest around organ donation that followed the Humboldt Bronco bus crash tragedy and related ``Logan Boulet Effect.'' The 2019-2020 and 2020-2021 provincial budgets included dedicated funding for the development and launch of the registry, which was accompanied by a media campaign to increase public awareness. Though it is too early to evaluate the success of the registry, early indications suggest donation rates will be a key evaluation metric. Registries are commonly thought to help increase public awareness of, and support for, organ donation, but improving Saskatchewan's organ donation rates will likely also require companion measures to strengthen the culture and practice of donation in the province.
- 21 October 2021
- Published by Health Reform Observer - Observatoire des Reformes de Sante in Health Reform Observer – Observatoire des Réformes de Santé
- Vol. 9 (2)
Introducing an Organ Donor Registry is Saskatchewan
On 3 September 2020, Saskatchewan launched an organ donor registry that allows participants 16 years and older to register their intent to be an organ donor either online or using a paper form. Saskatchewan has historically performed poorly at a national level with low rates of organ donations. Saskatchewan's new registry is intended to increase the numbers of organ donors in the province, while also helping to modernize its organ donation system and ease donation conversations with families. Saskatchewan's introduction of this registry brought the province in line with other provinces and territories across Canada that use similar systems, and provided a response to the surge in public interest around organ donation that followed the Humboldt Bronco bus crash tragedy and related ``Logan Boulet Effect.'' The 2019-2020 and 2020-2021 provincial budgets included dedicated funding for the development and launch of the registry, which was accompanied by a media campaign to increase public awareness. Though it is too early to evaluate the success of the registry, early indications suggest donation rates will be a key evaluation metric. Registries are commonly thought to help increase public awareness of, and support for, organ donation, but improving Saskatchewan's organ donation rates will likely also require companion measures to strengthen the culture and practice of donation in the province.
- 10 December 2020
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 34 (3) , 169-174
Artificial intelligence-based imaging analytics and lung cancer diagnostics: Considerations for health system leaders
Lung cancer is a leading cause of cancer death in Canada, and accurate, early diagnosis are critical to improving clinical outcomes. Artificial Intelligence (AI)-based imaging analytics are a promising healthcare innovation that aim to improve the accuracy and efficiency of lung cancer diagnosis. Maximizing their clinical potential while mitigating their risks and limitations will require focused leadership informed by interdisciplinary expertise and system-wide insight. We convened a knowledge exchange workshop with diverse Saskatchewan health system leaders and stakeholders to explore issues surrounding the use of AI in diagnostic imaging for lung cancer, including implementation opportunities, challenges, and priorities. This technology is anticipated to improve patient outcomes, reduce unnecessary healthcare spending, and increase knowledge. However, health system leaders must also address the needs for robust data, financial investment, effective communication and collaboration between healthcare sectors, privacy and data protections, and continued interdisciplinary research to achieve this technology’s potential benefits.
- 10 December 2020
- Published by SAGE Publications in Healthcare Management Forum
- Vol. 34 (3) , 169-174
Artificial intelligence-based imaging analytics and lung cancer diagnostics: Considerations for health system leaders
Lung cancer is a leading cause of cancer death in Canada, and accurate, early diagnosis are critical to improving clinical outcomes. Artificial Intelligence (AI)-based imaging analytics are a promising healthcare innovation that aim to improve the accuracy and efficiency of lung cancer diagnosis. Maximizing their clinical potential while mitigating their risks and limitations will require focused leadership informed by interdisciplinary expertise and system-wide insight. We convened a knowledge exchange workshop with diverse Saskatchewan health system leaders and stakeholders to explore issues surrounding the use of AI in diagnostic imaging for lung cancer, including implementation opportunities, challenges, and priorities. This technology is anticipated to improve patient outcomes, reduce unnecessary healthcare spending, and increase knowledge. However, health system leaders must also address the needs for robust data, financial investment, effective communication and collaboration between healthcare sectors, privacy and data protections, and continued interdisciplinary research to achieve this technology’s potential benefits.
- 1 December 2019
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 14 (12) , 1137-1150
Contact Us for More Information: An Analysis of Public Enquiries about Stem Cells
Aim: This study examines online enquiries received by two prominent stem cell science initiatives operating in different geographical jurisdictions. Materials & methods: Combined quantitative and qualitative analysis undertaken of internet-based queries (n = 1047) received by Stem Cells Australia and EuroStem-Cell from members of the public over a two-year period (May 2014-2016). Results: Findings reveal striking similarities between the two datasets and highlight the range of uncertainties, priorities and needs of those seeking information about stem cells online. Conclusion: Sustained and in-depth tailored guidance is needed to effectively meet the diverse stem cell-related information-based needs of communities internationally. Such efforts should be prioritized by regenerative medicine research initiatives and organizations, given the trust and hope diverse publics appear to place in these groups.
- 1 December 2019
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 14 (12) , 1137-1150
Contact Us for More Information: An Analysis of Public Enquiries about Stem Cells
Aim: This study examines online enquiries received by two prominent stem cell science initiatives operating in different geographical jurisdictions. Materials & methods: Combined quantitative and qualitative analysis undertaken of internet-based queries (n = 1047) received by Stem Cells Australia and EuroStem-Cell from members of the public over a two-year period (May 2014-2016). Results: Findings reveal striking similarities between the two datasets and highlight the range of uncertainties, priorities and needs of those seeking information about stem cells online. Conclusion: Sustained and in-depth tailored guidance is needed to effectively meet the diverse stem cell-related information-based needs of communities internationally. Such efforts should be prioritized by regenerative medicine research initiatives and organizations, given the trust and hope diverse publics appear to place in these groups.
- 21 November 2019
- Published by Springer Nature
- p. 1-16
The Future of Stem Cell Research and its Clinical Translation in Canada: Exploring Questions of Governance and Policy Options
Stem cell research is a promising area of biomedical research with tremendous potential for increasing our understanding of human development and for improving clinical treatment options across a range of serious conditions. However, it has historically also been a complex field, both scientifically and ethically. It raises numerous policy tensions including those related to the acceptability of different forms of research in the field and, more recently, regarding how to respond to the rapidly growing private market for clinical applications that lack broadly accepted forms of evidence of safety and efficacy. Using the Canadian market for unproven stem cell interventions as a case study, this review paper identifies questions of governance and policy options as they relate to the future of stem cell research and its clinical translation in Canada. Key areas of inquiry include the roles and influence of evidence, scientific and clinical imperatives, and public pressure on policy decisions, as well as the role of regulation in managing risks and uncertainty in fast moving fields of biomedicine. Examining these questions in a Canadian context is particularly timely at present given the emerging domestic private market for stem cell-based interventions coupled with scientific developments in the field that are highlighting ambiguities and other challenges with our current regulatory framework.
- 21 November 2019
- Published by Springer Nature
- p. 1-16
The Future of Stem Cell Research and its Clinical Translation in Canada: Exploring Questions of Governance and Policy Options
Stem cell research is a promising area of biomedical research with tremendous potential for increasing our understanding of human development and for improving clinical treatment options across a range of serious conditions. However, it has historically also been a complex field, both scientifically and ethically. It raises numerous policy tensions including those related to the acceptability of different forms of research in the field and, more recently, regarding how to respond to the rapidly growing private market for clinical applications that lack broadly accepted forms of evidence of safety and efficacy. Using the Canadian market for unproven stem cell interventions as a case study, this review paper identifies questions of governance and policy options as they relate to the future of stem cell research and its clinical translation in Canada. Key areas of inquiry include the roles and influence of evidence, scientific and clinical imperatives, and public pressure on policy decisions, as well as the role of regulation in managing risks and uncertainty in fast moving fields of biomedicine. Examining these questions in a Canadian context is particularly timely at present given the emerging domestic private market for stem cell-based interventions coupled with scientific developments in the field that are highlighting ambiguities and other challenges with our current regulatory framework.
- Open Access
- 20 March 2019
- Published by Consortium Erudit in Canadian Journal of Bioethics / Revue Canadienne de Bioéthique
- Vol. 2 (2) , 52-60
Health Misinformation and the Power of Narrative Messaging in the Public Sphere
Numerous social, economic and academic pressures can have a negative impact on representations of biomedical research. We review several of the forces playing an increasingly pernicious role in how health and science information is interpreted, shared and used, drawing discussions towards the role of narrative. In turn, we explore how aspects of narrative are used in different social contexts and communication environments, and present creative responses that may help counter the negative trends. As traditional methods of communication have in many ways failed the public, changes in approach are required, including the creative use of narratives.
- 20 March 2019
- Published by Consortium Erudit in Canadian Journal of Bioethics / Revue Canadienne de Bioéthique
- Vol. 2 (2) , 52-60
Open AccessHealth Misinformation and the Power of Narrative Messaging in the Public Sphere
Numerous social, economic and academic pressures can have a negative impact on representations of biomedical research. We review several of the forces playing an increasingly pernicious role in how health and science information is interpreted, shared and used, drawing discussions towards the role of narrative. In turn, we explore how aspects of narrative are used in different social contexts and communication environments, and present creative responses that may help counter the negative trends. As traditional methods of communication have in many ways failed the public, changes in approach are required, including the creative use of narratives.
- Open Access
- 20 November 2018
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 5 (3) , 743-758
The stem cell market and policy options: a call for clarity
The field of regenerative medicine is widely viewed as having the potential to improve treatment options for a broad range of conditions. Stem cell research in particular has been celebrated for its considerable clinical promise. Although measured enthusiasm surrounding this area of research is warranted, it must be balanced by patience and set in the context of a long-term perspective that is cognizant of the many steps required to bring safe and efficacious therapies to market. Creating therapeutic applications of stem cell technologies is an intricate process involving complex biology. It will require careful scientific investigation and evaluation under responsible ethical frameworks and regulatory standards in order to safely maximize their potential. Alongside the many promising avenues of responsible research currently underway in countries throughout the world, a global market has emerged where a wide range of putative stem cell-based interventions are sold on a direct-to-consumer basis and marketed over the internet.1,2,3,4
- 20 November 2018
- Published by Oxford University Press (OUP) in Journal of Law and the Biosciences
- Vol. 5 (3) , 743-758
Open AccessThe stem cell market and policy options: a call for clarity
The field of regenerative medicine is widely viewed as having the potential to improve treatment options for a broad range of conditions. Stem cell research in particular has been celebrated for its considerable clinical promise. Although measured enthusiasm surrounding this area of research is warranted, it must be balanced by patience and set in the context of a long-term perspective that is cognizant of the many steps required to bring safe and efficacious therapies to market. Creating therapeutic applications of stem cell technologies is an intricate process involving complex biology. It will require careful scientific investigation and evaluation under responsible ethical frameworks and regulatory standards in order to safely maximize their potential. Alongside the many promising avenues of responsible research currently underway in countries throughout the world, a global market has emerged where a wide range of putative stem cell-based interventions are sold on a direct-to-consumer basis and marketed over the internet.1,2,3,4
- Open Access
- 16 July 2018
- Published by Springer Nature in Globalization and Health
- Vol. 14 (1) , 68
Medical tourism and national health care systems: an institutionalist research agenda
Although a growing body of literature has emerged to study medical tourism and address the policy challenges it creates for national health care systems, the comparative scholarship on the topic remains too limited in scope. In this article, we draw on the existing literature to discuss a comparative research agenda on medical tourism that stresses the multifaceted relationship between medical tourism and the institutional characteristics of national health care systems. On the one hand, we claim that such characteristics shape the demand for medical tourism in each country. On the other hand, the institutional characteristics of each national health care system can shape the very nature of the impact of medical tourism on that particular country. Using the examples of Canada and the United States, this article formulates a systematic institutionalist research agenda to explore these two related sides of the medical tourism-health care system nexus with a view to informing future policy work in this field.
- 16 July 2018
- Published by Springer Nature in Globalization and Health
- Vol. 14 (1) , 68
Open AccessMedical tourism and national health care systems: an institutionalist research agenda
Although a growing body of literature has emerged to study medical tourism and address the policy challenges it creates for national health care systems, the comparative scholarship on the topic remains too limited in scope. In this article, we draw on the existing literature to discuss a comparative research agenda on medical tourism that stresses the multifaceted relationship between medical tourism and the institutional characteristics of national health care systems. On the one hand, we claim that such characteristics shape the demand for medical tourism in each country. On the other hand, the institutional characteristics of each national health care system can shape the very nature of the impact of medical tourism on that particular country. Using the examples of Canada and the United States, this article formulates a systematic institutionalist research agenda to explore these two related sides of the medical tourism-health care system nexus with a view to informing future policy work in this field.